Biopsy-proven renal involvement and prognosis in 13 hispanic patients with primary Sjogren syndrome

被引:4
作者
Luis Carrillo-Perez, Diego [1 ]
Tejeda-Maldonado, Javier [1 ]
Garza-Garcia, Carlos [2 ]
Soto-Abraham, Virgilia [3 ]
Hernandez-Molina, Gabriela [4 ]
Arnoldo Molina-Paredes, Giovanni [5 ]
Uribe-Uribe, Norma O. [5 ]
Morales-Buenrostro, Luis E. [1 ]
机构
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Nefrol & Metab Mineral, Ciudad De Mexico, Mexico
[2] Inst Nacl Cardiol Ignacio Chavez, Dept Nefrol, Ciudad De Mexico, Mexico
[3] Inst Nacl Cardiol Ignacio Chavez, Dept Patol, Ciudad De Mexico, Mexico
[4] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Inmunol & Reumatol, Ciudad De Mexico, Mexico
[5] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Patol, Ciudad De Mexico, Mexico
来源
MEDICINA CLINICA | 2018年 / 150卷 / 02期
关键词
Sjogren syndrome; Glomerulonephritis; Interstitial nephritis; Biopsy; Hispanic; ANTIBODIES; DISEASE;
D O I
10.1016/j.medcli.2017.06.050
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The aim of this study was to describe a case series of 13 Hispanic patients with primary Sjogren syndrome (pSS) and biopsy-proven renal involvement. Methods: We describe the clinical, serological and histological characteristics as well as the prognosis in a group of patients with pSS and biopsy-proven renal involvement, treated in 2 referral nephrology units in Mexico City. Results: Thirteen patients with pSS underwent kidney biopsy (KB) over a period of 27 years. The median duration from pSS diagnosis to KB was 13.9 months. Seven patients (54%) had glomerulonephritis and 6 patients (46%) had tubulointerstitial nephritis. All patients were treated with corticosteroids and/or immunosuppressants. Eight patients (62%) remained stable or their renal function improved after a median follow-up of 12 months. Conclusions: This case series reflects the broad spectrum of renal involvement in pSS. We observed that in our Hispanic population, glomerular involvement was the most frequent abnormality, mainly membranous glomerulopathy, followed by tubulointerstitial disease. Tubular atrophy and interstitial fibrosis were also common biopsy findings. Treatment with corticosteroids or other immunosuppressive agents appear to slow renal disease progression. (C) 2017 Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:43 / 48
页数:6
相关论文
共 19 条
[1]   Primary Sjogren's syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients [J].
Baldini, Chiara ;
Pepe, Pasquale ;
Quartuccio, Luca ;
Priori, Roberta ;
Bartoloni, Elena ;
Alunno, Alessia ;
Gattamelata, Angelica ;
Maset, Marta ;
Modesti, Mariagrazia ;
Tavoni, Antonio ;
De Vita, Salvatore ;
Gerli, Roberto ;
Valesini, Guido ;
Bombardieri, Stefano .
RHEUMATOLOGY, 2014, 53 (05) :839-844
[2]   Clinical and morphological features of kidney involvement in primary Sjogren's syndrome [J].
Bossini, N ;
Savoldi, S ;
Franceschini, F ;
Mombelloni, S ;
Baronio, M ;
Cavazzana, I ;
Viola, BF ;
Valzorio, B ;
Mazzucchelli, C ;
Cattaneo, R ;
Scolari, F ;
Maiorca, R .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (12) :2328-2336
[3]   Quantitative assessment of antibodies to ribonucleoproteins in primary Sjogren syndrome: correlation with B-cell biomarkers and disease activity [J].
Candon, S. ;
Gottenberg, J. E. ;
Bengoufa, D. ;
Chatenoud, L. ;
Mariette, X. .
ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (07) :1208-1212
[4]   Tubulointerstitial nephritis in primary Sjogren syndrome: clinical manifestations and response to treatment [J].
Evans, Rhys D. R. ;
Laing, Christopher M. ;
Ciurtin, Coziana ;
Walsh, Stephen B. .
BMC MUSCULOSKELETAL DISORDERS, 2016, 17
[5]   Renal involvement in primary Sjogren syndrome [J].
Francois, Helene ;
Mariette, Xavier .
NATURE REVIEWS NEPHROLOGY, 2016, 12 (02) :82-93
[6]   Clinically significant and biopsy-documented renal involvement in primary Sjogren syndrome [J].
Goules, A ;
Masouridi, S ;
Tziofas, AG ;
Ioannidis, JPA ;
Skopouli, FN ;
Moutsopoulos, HM .
MEDICINE, 2000, 79 (04) :241-249
[7]   Clinically Significant Renal Involvement in Primary Sjogren's Syndrome [J].
Goules, Andreas V. ;
Tatouli, Ioanna P. ;
Moutsopoulos, Haralampos M. ;
Tzioufas, Athanasios G. .
ARTHRITIS AND RHEUMATISM, 2013, 65 (11) :2945-2953
[8]   The meaning of anti-Ro and anti-La antibodies in primary Sjogren's syndrome [J].
Hernandez-Molina, Gabriela ;
Leal-Alegre, Gustavo ;
Michel-Peregrina, Martha .
AUTOIMMUNITY REVIEWS, 2011, 10 (03) :123-125
[9]   A multicentre study of 95 biopsy-proven cases of renal disease in primary Sjogren's syndrome [J].
Jasiek, Magali ;
Karras, Alexandre ;
Le Guern, Veronique ;
Krastinova, Evguenia ;
Mesbah, Rafik ;
Faguer, Stanislas ;
Jourde-Chiche, Noemie ;
Fauchais, Anne-Laure ;
Chiche, Laurent ;
Dernis, Emmanuelle ;
Moulis, Guillaume ;
Fraison, Jean-Baptiste ;
Lazaro, Estibaliz ;
Jullien, Perrine ;
Hachulla, Eric ;
Le Quellec, Alain ;
Remy, Philippe ;
Hummel, Aurelie ;
Costedoat-Chalumeau, Nathalie ;
Ronco, Pierre ;
Vanhille, Philippe ;
Meas-Yedid, Vannary ;
Cordonnier, Carole ;
Ferlicot, Sophie ;
Daniel, Laurent ;
Seror, Raphaele ;
Mariette, Xavier ;
Thervet, Eric ;
Francois, Helene ;
Terrier, Benjamin .
RHEUMATOLOGY, 2017, 56 (03) :362-370
[10]   Sjogren's syndrome - not just Sicca: renal involvement in Sjogren's syndrome [J].
Kaufman, I. ;
Schwartz, D. ;
Caspi, D. ;
Paran, D. .
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2008, 37 (03) :213-218